Shattuck Labs (STTK) Net Cash Flow (2019 - 2026)
Shattuck Labs (STTK) posted quarterly Net Cash Flow of $36.2 million for Q1 2026, up 931.81% year-over-year from $3.5 million in Q1 2025, and up 211.12% quarter-over-quarter from $11.6 million in Q4 2025.
Shattuck Labs (STTK) Net Cash Flow (2019 - 2026) Analysis & Trends
Shattuck Labs (STTK) has reported Net Cash Flow for 8 consecutive years, with $36.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Net Cash Flow rose 931.81% year-over-year to $36.2 million; the TTM figure through Mar 2026 stood at $29.5 million (up 295.41% YoY), while the FY2025 annual figure was -$3.2 million, up 95.32% from the prior year.
- Net Cash Flow rose to $36.2 million in Q1 2026 per STTK's latest filing, from $11.6 million in the prior quarter.
- Across five years, Net Cash Flow topped out at $85.0 million in Q4 2023 and bottomed at -$49.6 million in Q1 2024.
- Historically, Net Cash Flow has averaged -$108764.7 across 5 years, with a median of $1.9 million in 2022.
- On a YoY basis, Net Cash Flow climbed as much as 1015.26% in 2023 and fell as far as 1755.77% in 2023.
- Shattuck Labs' Net Cash Flow stood at $7.6 million in 2022, then jumped by 1015.26% to $85.0 million in 2023, then tumbled by 84.05% to $13.6 million in 2024, then slipped by 14.12% to $11.6 million in 2025, then surged by 211.12% to $36.2 million in 2026.
- Business Quant data shows STTK's Net Cash Flow at $36.2 million in Q1 2026, $11.6 million in Q4 2025, and -$7.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 652.90 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -504.30 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 374.50 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 407.41 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 17.81 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 225.59 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -496,000.00 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -37.14 Mn |
| 10 | Shattuck Labs | 962.96 Mn | 962.96 Mn | - | -27.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -27.12 Mn |
| Jun 30, 2026 | -27.12 Mn |
| Mar 31, 2026 | 36.23 Mn |
| Mar 31, 2026 | 36.23 Mn |
| Dec 31, 2025 | 11.64 Mn |
| Dec 31, 2025 | 11.64 Mn |
| Sep 30, 2025 | -7.92 Mn |
| Sep 30, 2025 | -7.92 Mn |
| Jun 30, 2025 | -10.43 Mn |
| Jun 30, 2025 | -10.43 Mn |
| Mar 31, 2025 | 3.51 Mn |
| Mar 31, 2025 | 3.51 Mn |
| Dec 31, 2024 | 13.56 Mn |
| Dec 31, 2024 | 13.56 Mn |
| Sep 30, 2024 | -16.86 Mn |
| Sep 30, 2024 | -16.86 Mn |
| Jun 30, 2024 | -15.31 Mn |
| Jun 30, 2024 | -15.31 Mn |
| Mar 31, 2024 | -49.62 Mn |
| Mar 31, 2024 | -49.62 Mn |